Consistent cell culture processing outsourcing from necessary document preparation to quality testing! Our outsourcing services.
Our company has had the opportunity to provide various services such as the construction of cell culture processing facilities, cell culture support, facility operation management support, document preparation support, and quality testing outsourcing, accumulating experience and know-how. In order to utilize this experience for the early realization of regenerative medicine and cell therapy, we are expanding our contract services for cell culture processing. We comprehensively undertake cell culture processing, including the preparation of necessary documents such as procedures, instructions, and records, the construction of facilities suitable for our clients' cells, preliminary tests and culture by experienced staff, and the establishment and implementation of various performance and quality tests. 【Service Contents】 ■ Document preparation ■ Optimization of culture facilities ■ Cell culture ■ Establishment of various performance and quality tests *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Cell culture processing *For more details, please refer to the related links or feel free to contact us.
Company information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.